Literature DB >> 18005778

Management of T2 gallbladder cancer: are practice patterns consistent with national recommendations?

Byron E Wright1, Chris C Lee, Douglas M Iddings, Maihgan Kavanagh, Anton J Bilchik.   

Abstract

BACKGROUND: The national recommendation for the management of localized T2 gallbladder cancer (GBCA) is radical cholecystectomy. Although reported survival for localized T2 disease has been poor, groups have documented improvement with radical resection. We hypothesized that a discrepancy exists between national recommendations and current practice patterns.
METHODS: Patients diagnosed with localized T2 GBCA between 1988 and 2002 were identified from the Surveillance, Epidemiology, and End Results registry. Age, sex, race, ethnicity, extent of surgery, and overall survival were assessed. Surgical procedure was categorized as cholecystectomy alone (CS), cholecystectomy plus lymph node dissection (CS+LN), radical cholecystectomy (RCS), or other. Survival calculations were made using the Kaplan-Meier method and compared with the log-rank test.
RESULTS: Of 382 patients with pathologically confirmed T2 GBCA, 280 were women. The median patient age was 75 years. A total of 238 patients underwent CS, 76 underwent CS+LN, and 14 underwent RCS. The remaining 54 patients underwent a lesser or no procedure and were excluded from comparative analysis. The median survival was 14 months for all patients and 14, 14, and 8 months for subgroups treated with CS, CS+LN, and RCS, respectively. Rates of 5-year survival were 23%, 24%, and 36% for CS, CS+LN, and RCS subgroups, respectively. There was no significant difference in survival rates between RCS and CS+LN, or between RCS and CS.
CONCLUSIONS: The majority of patients with T2 GBCA in the United States are not managed according to current national recommendations.

Entities:  

Mesh:

Year:  2007        PMID: 18005778     DOI: 10.1016/j.amjsurg.2007.08.032

Source DB:  PubMed          Journal:  Am J Surg        ISSN: 0002-9610            Impact factor:   2.565


  16 in total

1.  What to do when the pathology from last week's laparoscopic cholecystectomy is malignant and T1 or T2.

Authors:  K M Hardiman; B C Sheppard
Journal:  J Gastrointest Surg       Date:  2009-02-14       Impact factor: 3.452

2.  Role of cholecystectomy and lymph node dissection in patients with T2 gallbladder cancer.

Authors:  Dong Hyun Kim; Sung Hoon Kim; Gi Hong Choi; Chang Moo Kang; Kyung Sik Kim; Jin Sub Choi; Woo Jung Lee
Journal:  World J Surg       Date:  2013-11       Impact factor: 3.352

3.  Tumor location is a strong predictor of tumor progression and survival in T2 gallbladder cancer: an international multicenter study.

Authors:  Junichi Shindoh; Xabier de Aretxabala; Thomas A Aloia; Juan Carlos Roa; Ivan Roa; Giuseppe Zimmitti; Milind Javle; Claudius Conrad; Dipen M Maru; Taku Aoki; Luca Vigano; Dario Ribero; Norihiro Kokudo; Lorenzo Capussotti; Jean-Nicolas Vauthey
Journal:  Ann Surg       Date:  2015-04       Impact factor: 12.969

4.  Benefit of extended radical surgery for incidental gallbladder carcinoma.

Authors:  Junpei Yamaguchi; Yuji Kaneoka; Atsuyuki Maeda; Yuichi Takayama; Shunsuke Onoe; Masatoshi Isogai
Journal:  Surg Today       Date:  2015-06-17       Impact factor: 2.549

5.  Influence of high- and low-volume liver surgery in gallbladder carcinoma.

Authors:  Thorsten Oliver Goetze; Vittorio Paolucci
Journal:  World J Gastroenterol       Date:  2014-12-28       Impact factor: 5.742

6.  T2 gallbladder cancer shows substantial survival variation between continents and this is not due to histopathologic criteria or pathologic sampling differences.

Authors:  Mia S DeSimone; Michael Goodman; Burcin Pehlivanoglu; Bahar Memis; Serdar Balci; Juan Carlos Roa; Kee-Taek Jang; Jin-Young Jang; Seung-Mo Hong; Kyoungbun Lee; Haeryoung Kim; Hye-Jeong Choi; Takashi Muraki; Juan Carlos Araya; Enrique Bellolio; Juan M Sarmiento; Shishir K Maithel; Hector F Losada; Olca Basturk; Michelle D Reid; Jill Koshiol; Volkan Adsay
Journal:  Virchows Arch       Date:  2021-01-07       Impact factor: 4.064

7.  Surgical treatment of incidental gallbladder cancer discovered during or following laparoscopic cholecystectomy.

Authors:  Yuan-Hu Tian; Xu Ji; Bo Liu; Guang-Yun Yang; Xiang-Fei Meng; Hong-Tian Xia; Jing Wang; Zhi-Qiang Huang; Jia-Hong Dong
Journal:  World J Surg       Date:  2015-03       Impact factor: 3.352

8.  The prognostic impact of positive lymph nodes in stages T1 to T3 incidental gallbladder carcinoma: results of the German Registry.

Authors:  Thorsten Oliver Goetze; Vittorio Paolucci
Journal:  Surg Endosc       Date:  2011-11-17       Impact factor: 4.584

9.  A critical analysis of the surgical management of early-stage gallbladder cancer in the United States.

Authors:  Eric H Jensen; Anasooya Abraham; Elizabeth B Habermann; Waddah B Al-Refaie; Selwyn M Vickers; Beth A Virnig; Todd M Tuttle
Journal:  J Gastrointest Surg       Date:  2008-12-13       Impact factor: 3.452

10.  Gallbladder cancer: we need to do better!

Authors:  Parul J Shukla; Savio G Barreto
Journal:  Ann Surg Oncol       Date:  2009-06-09       Impact factor: 5.344

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.